Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 83

The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.

6-Phosphofructo-2-kinase/fructose-2,6-biphosphatase 4 is essential for p53-null cancer cells

Ros, S, Flöter, J, Kaymak, I, Da Costa, C, Houddane, A, Dubuis, S, Griffiths, B, Mitter, R, Walz, S, Blake, S, Behrens, A, Brindle, K M, Zamboni, N, Rider, M H, Schulze, A · 2017 · Oncogene

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/onc.2016.477

Cites

14 of 14 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 31

  1. Li T, Kon N, Jiang L, Tan M, Ludwig T, Zhao Y et al. Tumor suppression in the absence of p53-mediated cell-cycle arrest, apoptosis, and senescence. Cell 2012; 149: 1269–1283. · DOI · Paper page
  2. Kawauchi K, Araki K, Tobiume K, Tanaka N . p53 regulates glucose metabolism through an IKK-NF-kappaB pathway and inhibits cell transformation. Nat Cell Biol 2008; 10: 611–618. · DOI · Paper page
  3. Hitosugi T, Zhou L, Elf S, Fan J, Kang HB, Seo JH et al. Phosphoglycerate mutase 1 coordinates glycolysis and biosynthesis to promote tumor growth. Cancer Cell 2012; 22: 585–600. · DOI · Paper page
  4. Jiang P, Du W, Wang X, Mancuso A, Gao X, Wu M et al. p53 regulates biosynthesis through direct inactivation of glucose-6-phosphate dehydrogenase. Nat Cell Biol 2011; 13: 310–316. · DOI · Paper page
  5. Ros S, Santos CR, Moco S, Baenke F, Kelly G, Howell M et al. Functional metabolic screen identifies 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 4 as an important regulator of prostate cancer cell survival. Cancer Discov 2012; 2: 328–343. · DOI · Paper page
  6. Ho J, Benchimol S . Transcriptional repression mediated by the p53 tumour suppressor. Cell Death Differ 2003; 10: 404–408. · DOI · Paper page
  7. Murphy M, Ahn J, Walker KK, Hoffman WH, Evans RM, Levine AJ et al. Transcriptional repression by wild-type p53 utilizes histone deacetylases, mediated by interaction with mSin3a. Genes Dev 1999; 13: 2490–2501. · DOI · Paper page
  8. Okar DA, Manzano A, Navarro-Sabate A, Riera L, Bartrons R, Lange AJ . PFK-2/FBPase-2: maker and breaker of the essential biofactor fructose-2,6-bisphosphate. Trends Biochem Sci 2001; 26: 30–35. · DOI · Paper page
  9. Strohecker AM, Joshi S, Possemato R, Abraham RT, Sabatini DM, White E . Identification of 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase as a novel autophagy regulator by high content shRNA screening. Oncogene 2015; 34: 5662–5676. · DOI
  10. Willis A, Jung EJ, Wakefield T, Chen X . Mutant p53 exerts a dominant negative effect by preventing wild-type p53 from binding to the promoter of its target genes. Oncogene 2004; 23: 2330–2338. · DOI · Paper page
  11. Schwartzenberg-Bar-Yoseph F, Armoni M, Karnieli E . The tumor suppressor p53 down-regulates glucose transporters GLUT1 and GLUT4 gene expression. Cancer Res 2004; 64: 2627–2633. · DOI · Paper page
  12. Bengoechea-Alonso MT, Ericsson J . SREBP in signal transduction: cholesterol metabolism and beyond. Curr Opin Cell Biol 2007; 19: 215–222. · DOI · Paper page
  13. Freed-Pastor WA, Mizuno H, Zhao X, Langerod A, Moon SH, Rodriguez-Barrueco R et al. Mutant p53 disrupts mammary tissue architecture via the mevalonate pathway. Cell 2012; 148: 244–258. · DOI · Paper page
  14. Yahagi N, Shimano H, Matsuzaka T, Najima Y, Sekiya M, Nakagawa Y et al. p53 Activation in adipocytes of obese mice. J Biol Chem 2003; 278: 25395–25400. · DOI · Paper page
  15. Mayers JR, Vander Heiden MG . Famine versus feast: understanding the metabolism of tumors in vivo. Trends Biochem Sci 2015; 40: 130–140. · DOI · Paper page
  16. Casciari JJ, Sotirchos SV, Sutherland RM . Variations in tumor cell growth rates and metabolism with oxygen concentration, glucose concentration, and extracellular pH. J Cell Physiol 1992; 151: 386–394. · DOI · Paper page
  17. Maddocks OD, Vousden KH . Metabolic regulation by p53. J Mol Med 2011; 89: 237–245. · DOI · Paper page
  18. Kim HR, Roe JS, Lee JE, Cho EJ, Youn HD . p53 regulates glucose metabolism by miR-34a. Biochem Biophys Res Commun 2013; 437: 225–231. · DOI
  19. Rinn JL, Huarte M . To repress or not to repress: this is the guardian's question. Trends Cell Biol 2011; 21: 344–353. · DOI
  20. Chesney J, Clark J, Klarer AC, Imbert-Fernandez Y, Lane AN, Telang S . Fructose-2,6-bisphosphate synthesis by 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 4 (PFKFB4) is required for the glycolytic response to hypoxia and tumor growth. Oncotarget 2014; 5: 6670–6686. · DOI
  21. Laplante M, Sabatini DM . An emerging role of mTOR in lipid biosynthesis. Curr Biol 2009; 19: R1046–R1052. · DOI · Paper page
  22. Ralser M, Wamelink MM, Kowald A, Gerisch B, Heeren G, Struys EA et al. Dynamic rerouting of the carbohydrate flux is key to counteracting oxidative stress. J Biol 2007; 6: 10. · DOI · Paper page
  23. Van Schaftingen E, Lederer B, Bartrons R, Hers HG . A kinetic study of pyrophosphate: fructose-6-phosphate phosphotransferase from potato tubers. Application to a microassay of fructose 2,6-bisphosphate. Eur J Biochem 1982; 129: 191–195. · DOI · Paper page
  24. Buescher JM, Moco S, Sauer U, Zamboni N . Ultrahigh performance liquid chromatography-tandem mass spectrometry method for fast and robust quantification of anionic and aromatic metabolites. Anal Chem 2010; 82: 4403–4412. · DOI · Paper page
  25. Ruhl M, Rupp B, Noh K, Wiechert W, Sauer U, Zamboni N . Collisional fragmentation of central carbon metabolites in LC-MS/MS increases precision of (1)(3)C metabolic flux analysis. Biotechnol Bioeng 2012; 109: 763–771. · DOI
  26. Swinnen JV, Heemers H, Deboel L, Foufelle F, Heyns W, Verhoeven G . Stimulation of tumor-associated fatty acid synthase expression by growth factor activation of the sterol regulatory element-binding protein pathway. Oncogene 2000; 19: 5173–5181. · DOI · Paper page
  27. Huang, da W, Sherman BT, Lempicki RA . Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 2009; 4: 44–57. · DOI · Paper page
  28. Huang DW, Sherman BT, Tan Q, Kir J, Liu D, Bryant D et al. DAVID Bioinformatics resources: expanded annotation database and novel algorithms to better extract biology from large gene lists. Nucleic Acids Res 2007; 35: W169–W175. · DOI · Paper page
  29. Ivshina AV, George J, Senko O, Mow B, Putti TC, Smeds J et al. Genetic reclassification of histologic grade delineates new clinical subtypes of breast cancer. Cancer Res 2006; 66: 10292–10301. · DOI · Paper page
  30. Lee ES, Son DS, Kim SH, Lee J, Jo J, Han J et al. Prediction of recurrence-free survival in postoperative non-small cell lung cancer patients by using an integrated model of clinical information and gene expression. Clin Cancer Res 2008; 14: 7397–7404. · DOI · Paper page
  31. Goswami CP, Nakshatri H . PROGgene: gene expression based survival analysis web application for multiple cancers. J Clin Bioinform 2013; 3: 22. · DOI

Cited by

See all 83

Metadata

Authors
Ros, S., Flöter, J., Kaymak, I., Da Costa, C., Houddane, A., Dubuis, S., Griffiths, B., Mitter, R., Walz, S., Blake, S., Behrens, A., Brindle, K. M., Zamboni, N., Rider, M. H., & Schulze, A.
Venue
Oncogene
Published
2017-01-16
Volume
36
Issue
23
Pages
3287-3299
ISSN
  • 0950-9232
  • 1476-5594
Cited by
83
References
14
Language
en
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.